Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × binimetinib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gastrointestinal Stromal Tumors 3 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Temozolomide 43 Radiotherapy 19 Filgrastim 15 Carboplatin 14 Carmustine 13 Irinotecan 12 Bevacizumab 12 Surgical Procedures, Operative 9 Magnetic Resonance Spectroscopy 9 Erlotinib Hydrochloride 9 sargramostim 8 Peripheral Blood Stem Cell Transplantation 8 Radiation 7 O(6)-benzylguanine 7 Procarbazine 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 Topotecan 5 Thiotepa 5 Radiotherapy, Intensity-Modulated 5 Imatinib Mesylate 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Busulfan 5 Vorinostat 4 Vincristine 4 Thalidomide 4 Lomustine 4 Drug Therapy 4 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡